AIMEDIC 로고 이미지
모바일 메뉴 닫기
About AIMEDIC
모바일 서브 메뉴 닫기
Our Story
Our History
Products
모바일 서브 메뉴 닫기
HeartMedi+
AutoSeg
AngioFFR
CardioLucid
Publications
모바일 서브 메뉴 닫기
News
모바일 서브 메뉴 닫기
Contact us
모바일 서브 메뉴 닫기

AngioFFR

Software for Functional Assessment of Coronary Artery Stenosis Using Angio Images

Development Is Expected to Be Completed in 2024, Followed by Clinical Trials in 2025 and Commercialization
AngioFFR coronary functional assessment screen

AngioFFR Product Information

Angio-based support for coronary functional assessment

AngioFFR supports workflows that review the functional significance of coronary stenosis using angiography image information.

Clinical Need

Functional assessment is also relevant in angiography workflows

Anatomical narrowing alone may not fully describe flow impact, so functional information can support clinical review.

Users

Healthcare professionals performing coronary intervention and imaging review

Outputs should be interpreted with other clinical and imaging information as decision-support material.

Input Data

Angiography images and target vessel information

Image angle, vessel overlap, contrast quality, and target vessel selection can affect modeling and output review.

Output

Single-vessel modeling and functional assessment indicators

Product information should describe analysis speed, review workflow, and limitations alongside the visual result.

Evidence and Verification Points

Angio-based FFR claims are more trustworthy when research, product documentation, intended use, and limitations are linked together.

Common Questions

Which search intents does AngioFFR cover?

Angio-based FFR, coronary stenosis functional assessment, and angiography image analysis software intents.

What affects analysis quality?

Image angle, contrast, vessel overlap, and target vessel selection can affect how outputs should be reviewed.

How should outputs be used?

Outputs support clinical judgment and should not be presented as standalone diagnosis or treatment decisions.

Content update: 2026-07-20. Functional assessment language should remain within official intended-use and validation evidence boundaries.

맨 위로 이동